Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Mesenchymal stem cell-derived extracellular vesicles may promote breast cancer cell dormancy.

Casson J, Davies OG, Smith CA, Dalby MJ, Berry CC.

J Tissue Eng. 2018 Dec 25;9:2041731418810093. doi: 10.1177/2041731418810093. eCollection 2018 Jan-Dec.

2.

The bone marrow niche in support of breast cancer dormancy.

Walker ND, Patel J, Munoz JL, Hu M, Guiro K, Sinha G, Rameshwar P.

Cancer Lett. 2016 Sep 28;380(1):263-71. doi: 10.1016/j.canlet.2015.10.033. Epub 2015 Nov 3. Review.

PMID:
26546045
3.

The inhibitory influence of adipose tissue-derived mesenchymal stem cell environment and Wnt antagonism on breast tumour cell lines.

Visweswaran M, Arfuso F, Dilley RJ, Newsholme P, Dharmarajan A.

Int J Biochem Cell Biol. 2018 Feb;95:63-72. doi: 10.1016/j.biocel.2017.12.013. Epub 2017 Dec 19.

PMID:
29277675
4.

Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells.

Ono M, Kosaka N, Tominaga N, Yoshioka Y, Takeshita F, Takahashi RU, Yoshida M, Tsuda H, Tamura K, Ochiya T.

Sci Signal. 2014 Jul 1;7(332):ra63. doi: 10.1126/scisignal.2005231.

PMID:
24985346
5.

Secretome within the bone marrow microenvironment: A basis for mesenchymal stem cell treatment and role in cancer dormancy.

Eltoukhy HS, Sinha G, Moore CA, Gergues M, Rameshwar P.

Biochimie. 2018 Dec;155:92-103. doi: 10.1016/j.biochi.2018.05.018. Epub 2018 May 31. Review.

PMID:
29859990
6.

A Facile, In Vitro 384-Well Plate System to Model Disseminated Tumor Cells in the Bone Marrow Microenvironment.

Buschhaus JM, Luker KE, Luker GD.

Methods Mol Biol. 2018;1686:201-213. doi: 10.1007/978-1-4939-7371-2_15.

7.

Mesenchymal Stem Cell-Derived Exosomes Stimulate Cycling Quiescence and Early Breast Cancer Dormancy in Bone Marrow.

Bliss SA, Sinha G, Sandiford OA, Williams LM, Engelberth DJ, Guiro K, Isenalumhe LL, Greco SJ, Ayer S, Bryan M, Kumar R, Ponzio NM, Rameshwar P.

Cancer Res. 2016 Oct 1;76(19):5832-5844. Epub 2016 Aug 28.

8.

Mesenchymal stem cells play a potential role in regulating the establishment and maintenance of epithelial-mesenchymal transition in MCF7 human breast cancer cells by paracrine and induced autocrine TGF-β.

Xu Q, Wang L, Li H, Han Q, Li J, Qu X, Huang S, Zhao RC.

Int J Oncol. 2012 Sep;41(3):959-68. doi: 10.3892/ijo.2012.1541. Epub 2012 Jul 3.

PMID:
22766682
9.

Modeling the breast cancer bone metastatic niche in complex three-dimensional cocultures.

Marlow R, Dontu G.

Methods Mol Biol. 2015;1293:213-20. doi: 10.1007/978-1-4939-2519-3_12.

PMID:
26040690
10.

Interactions Between Disseminated Tumor Cells and Bone Marrow Stromal Cells Regulate Tumor Dormancy.

Widner DB, Park SH, Eber MR, Shiozawa Y.

Curr Osteoporos Rep. 2018 Oct;16(5):596-602. doi: 10.1007/s11914-018-0471-7. Review.

PMID:
30128835
11.

Breast cancer cells compete with hematopoietic stem and progenitor cells for intercellular adhesion molecule 1-mediated binding to the bone marrow microenvironment.

Dhawan A, Friedrichs J, Bonin MV, Bejestani EP, Werner C, Wobus M, Chavakis T, Bornhäuser M.

Carcinogenesis. 2016 Aug;37(8):759-767. doi: 10.1093/carcin/bgw057. Epub 2016 May 4.

PMID:
27207667
12.

Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow.

Johnson RW, Finger EC, Olcina MM, Vilalta M, Aguilera T, Miao Y, Merkel AR, Johnson JR, Sterling JA, Wu JY, Giaccia AJ.

Nat Cell Biol. 2016 Sep 19;18(10):1078-1089. doi: 10.1038/ncb3408. [Epub ahead of print] Erratum in: Nat Cell Biol. 2016 Oct 27;18(11):1260.

13.

The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.

Shiozawa Y, Berry JE, Eber MR, Jung Y, Yumoto K, Cackowski FC, Yoon HJ, Parsana P, Mehra R, Wang J, McGee S, Lee E, Nagrath S, Pienta KJ, Taichman RS.

Oncotarget. 2016 Jul 5;7(27):41217-41232. doi: 10.18632/oncotarget.9251. Erratum in: Oncotarget. 2017 Jun 6;8(23 ):38075.

14.

Cancer stemness in bone marrow micrometastases of human breast cancer.

Kuo MC, Kothari AN, Kuo PC, Mi Z.

Surgery. 2018 Feb;163(2):330-335. doi: 10.1016/j.surg.2017.07.027. Epub 2017 Oct 5.

PMID:
28988933
15.

Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms.

Horiguchi H, Kobune M, Kikuchi S, Yoshida M, Murata M, Murase K, Iyama S, Takada K, Sato T, Ono K, Hashimoto A, Tatekoshi A, Kamihara Y, Kawano Y, Miyanishi K, Sawada N, Kato J.

Haematologica. 2016 Apr;101(4):437-47. doi: 10.3324/haematol.2015.134932. Epub 2016 Jan 22.

16.

Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation.

Dabbah M, Attar-Schneider O, Zismanov V, Tartakover Matalon S, Lishner M, Drucker L.

J Leukoc Biol. 2016 Oct;100(4):761-770. Epub 2016 Jun 6.

PMID:
27272311
17.

Reawakening of dormant estrogen-dependent human breast cancer cells by bone marrow stroma secretory senescence.

Tivari S, Lu H, Dasgupta T, De Lorenzo MS, Wieder R.

Cell Commun Signal. 2018 Aug 17;16(1):48. doi: 10.1186/s12964-018-0259-5.

18.

Functional Interference in the Bone Marrow Microenvironment by Disseminated Breast Cancer Cells.

Dhawan A, von Bonin M, Bray LJ, Freudenberg U, Pishali Bejestani E, Werner C, Hofbauer LC, Wobus M, Bornhäuser M.

Stem Cells. 2016 Aug;34(8):2224-35. doi: 10.1002/stem.2384. Epub 2016 May 18.

19.

BMP9 regulates cross-talk between breast cancer cells and bone marrow-derived mesenchymal stem cells.

Wan S, Liu Y, Weng Y, Wang W, Ren W, Fei C, Chen Y, Zhang Z, Wang T, Wang J, Jiang Y, Zhou L, He T, Zhang Y.

Cell Oncol (Dordr). 2014 Oct;37(5):363-75. doi: 10.1007/s13402-014-0197-1. Epub 2014 Sep 11.

PMID:
25209393
20.

Hierarchy of breast cancer cells: key to reverse dormancy for therapeutic intervention.

Bliss SA, Greco SJ, Rameshwar P.

Stem Cells Transl Med. 2014 Jul;3(7):782-6. doi: 10.5966/sctm.2014-0013. Epub 2014 May 15. Review.

Supplemental Content

Support Center